The TRH-test in depression: a review

Area of Science:

• Endocrinology
• Psychiatry
• Neuroscience

Background:

• The thyrotropin releasing hormone (TRH)-test has been studied in patients with depression.
• Its utility as a diagnostic criterion and predictor of treatment response is under review.

Purpose of the Study:

• To review the literature on the TRH-test in depression.
• To evaluate its diagnostic accuracy, clinical utility, and underlying pathophysiology.

Main Methods:

• Literature review of studies investigating the TRH-test in depressive patients.
• Analysis of test sensitivity, specificity, and correlation with clinical diagnoses and treatment outcomes.

Main Results:

• The TRH-test shows some utility in validating major depression diagnoses, particularly melancholic vs. minor depression.
• Low sensitivity (±50%) and abnormal results in non-depressive disorders limit its clinical use.
• The test may predict response to biological therapies and has value for depressive episode outcomes.
• Abnormal TRH-tests are linked to noradrenergic/serotonergic dysfunctions, hypercortisolemia, and thyroid hormone abnormalities.
• Depression-linked abnormal TRH-tests correlate with lower basal TSH secretion.

Conclusions:

• The TRH-test has a limited role in diagnosing depression due to sensitivity issues and non-specific findings.
• It may serve as a predictor for treatment response and outcome.
• Lower basal TSH secretion is a potential future replacement for TRH-testing in depression assessment.